220876-16-4

Basic information

• Product Name: Cyclopentanecarboxylic acid, 1-(methoxymethyl)- (9CI)
• Synonyms: Cyclopentanecarboxylic acid, 1-(methoxymethyl)- (9CI)
• CAS NO: 220876-16-4
• Molecular Formula: C₈H₁₄O₃
• Molecular Weight: 158.19496
• Product Categories: CARBOXYLICACID
• Mol File: 220876-16-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Cyclopentanecarboxylic acid, 1-(methoxymethyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclopentanecarboxylic acid, 1-(methoxymethyl)- (9CI)(220876-16-4)
• EPA Substance Registry System: Cyclopentanecarboxylic acid, 1-(methoxymethyl)- (9CI)(220876-16-4)

Safety Data

• Hazardous Substances Data: 220876-16-4(Hazardous Substances Data)

Upstream product

• 1309166-05-9 ethyl 1-(methoxymethyl)cyclopentane carboxylate 
• 5453-85-0 ethyl cyclopentanecarboxylate 
• 3400-45-1 cyclopentanecarboxylic acid 
• 4630-80-2 methyl cyclopentane carboxylate 
• 220875-97-8 methyl 1-(methoxymethyl)cyclopentane carboxylate 

Downstream Products

• 1309165-06-7 N-((2S,3R)-4-(3-chloro-4-fluoro-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)-1-(methoxymethyl)cyclopentanecarboxamide 

Relevant articles and documents

NOVEL CARBOXAMIDE DERIVATIVES AS HIV INHIBITORS

The present invention relates to carboxamide derivatives of Formula (I), where B1, B2, X, L, n, R, R1, R2, Z1, Z2, Rx and Ry are as defined in the claims, as compounds and compositions for inhibiting Human Immunodeficiency Virus (HIV) and process for making the compounds.

2 -AMINOPYRIMIDINE DERIVATIVES AS HISTAMINE H4 ANTAGONISTS

2-Amino-pyrimidine derivatives of formula I, wherein the meaning of the different substituents are those indicated in the description. These compounds are useful as histamine receptor H4antagonists.

N-Cycloalkanoyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.

A systematic structure-activity relationship investigation of the lead compound 1 resulted the identification of several N-[(substituted alkyl)cycloalkanoyl]-4-[((2,6-dichlorophenyl)carbonyl)amino]-L-phenylalanine derivatives as potent VCAM/VLA-4 antagonists. The data are consistent with a model of these compounds in which these alkanoylphenylalanines reside in a compact gauche (-) bioactive conformation.